ROCKVILLE, Md.--(BUSINESS WIRE)-- Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the 29th Annual JPMorgan Healthcare Conference in San Francisco on Wednesday, January 12, 2011 at 11:30 AM Pacific. During the presentation, a member of the company’s senior management team will provide a corporate overview, including a discussion of product development programs, corporate activities, preliminary 2010 financial results and financial guidance for 2011.
A webcast of this presentation will be available both live and by replay, accessible from the company’s website www.emergentbiosolutions.com under “Investors”.
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a global biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the body’s immune system to prevent or treat disease. Emergent’s marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information may be found at www.emergentbiosolutions.com.
Emergent BioSolutions Inc.
Robert G. Burrows, 301-795-1877
Vice President, Investor Relations
Tracey Schmitt, 301-795-1800
Director, Corporate Communications
KEYWORDS: United States North America Maryland
INDUSTRY KEYWORDS: Health Biotechnology Infectious Diseases Pharmaceutical Other Health General Health